Ken Griffin Applied Molecular Transport Inc. Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.35 - $1.26 $56,700 - $204,120
-162,000 Reduced 95.18%
8,200 $3,000
Q3 2022

Nov 14, 2022
SELL
$1.12 - $3.12 $5,488 - $15,288
-4,900 Reduced 2.8%
170,200 $166,000

Others Institutions Holding AMTI

# of Institutions
1
Shares Held
9.42K
Call Options Held
0
Put Options Held
0
View Full List

About Applied Molecular Transport Inc.

AMTI Quotes by TradingView
  • Ticker AMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,900,600
  • Description
  • Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...
More about AMTI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email